HAS-BLED Score for Major Bleeding Risk

If high risk for bleeding: regular check-ups after start of oral anticoagulation

The HAS-BLED Score estimates 1‑year major bleeding risk in anticoagulated patients with atrial fibrillation 1.

History of Hypertension?
No0Yes+1
Renal Disease?
No0Yes+1
Liver Disease?
No0Yes+1
History of Stroke?
No0Yes+1
Prior Major Bleeding/Predisposed to bleeding?
No0Yes+1
Labile INR?
No0Yes+1
Older than 65 years old?
No0Yes+1
Medications that predispose to bleeding?
No0Yes+1
History of alcohol or drug usage?
No0Yes+1

Indications for Use

Used in adults with atrial fibrillation being considered for oral anticoagulation to flag high bleeding risk and guide modification of reversible factors—not to withhold therapy. Identifies hypertension, renal/hepatic dysfunction, prior stroke, prior bleeding, labile INR, age >65, and drugs/alcohol as risks (ACC/AHA 2023 AF Guideline 1 [Level I evidence]). Predicts major bleeding with modest discrimination and performs better than CHADS2/CHA2DS2‑VASc for bleeding (JACC 2013 2 [Level II evidence]).

Insights & Cautions

Identifies modifiable bleeding risks but should not guide anticoagulation decisions alone because predictive ability is only modest (c‑index ~0.58–0.59) per the 2023 ACC/AHA AF guideline 1 [Level I evidence]. High scores prompt correction of reversible factors (e.g., BP, NSAIDs, alcohol). External validations show balanced but limited discrimination 2 [Level II evidence]. A high score is not a reason to withhold OAC.